Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article about a patent that has been filed in Australia for EmtinB in combination with Copaxone as a potential MS treatment.
He also reads about a new CAR T-cell therapy that eliminates the self-reactive immune cells that drive MS without destroying healthy immune cells.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/

Podden och tillhörande omslagsbild på den här sidan tillhör MS News Today. Innehållet i podden är skapat av MS News Today och inte av, eller tillsammans med, Poddtoppen.